B.C. Reg. 9/2019: Regulation under the Pharmacy Operations and Drug Scheduling Act
Made under the Pharmacy Operations and Drug Scheduling Act
How does this rule affect your organization? One Click reads it against your profile and tells you, on Canada Federal Legislative Tracking. See plans →
Get alerted when the next rule lands
New rules land on their own schedule. Pick how you want to hear about them — we email you when one appears.
Publishing to members? Embed a live rule tracker on your own site — the proposed rules in your area and the comment deadlines closing on them, updating themselves. Free, one line of HTML.
The rule, in full
317 words as published, January 22, 2019. View the original →
B.C. Reg. 9/2019, deposited January 23, 2019, under the PHARMACY OPERATIONS AND DRUG SCHEDULING ACT [section 22 (1)]. Resolution of the Board of the College of Pharmacists of British Columbia, dated November 23, 2018. — B. NAKAGAWA, Registrar.
Appendix
1 The Drug Schedules Regulation, B.C. Reg. 9/98, is amended in the Schedules (a) by striking out the following: 1 Nicotine and its salts, for human use, except (a) in natural substances; (b) in the form of a chewing gum containing 4 mg or less of nicotine per dosage unit; (c) in the form of a transdermal patch with a delivery rate of 22 mg or less of nicotine per day; (d) in a form to be administered orally by means of an inhalation device delivering 4 mg or less of nicotine per dosage unit; or (e) in the form of a lozenge containing 4 mg or less of nicotine per dosage unit , and (b) by adding the following: 1 Codeine, except (a) when prescribed as a single entity, (b) when included in a preparation containing 60 mg or more per dosage unit, or (c) in preparations exempted from the Regulations to the Controlled Drugs and Substances Act (Canada) 1 Lisdexamfetamine dimesylate 1 Nicotine and its salts for human use, except (a) in natural substances, (b) in the form of a chewing gum containing 4 mg or less of nicotine per dosage unit, (c) in the form of a transdermal patch with a delivery rate of 22 mg or less of nicotine per day, (d) in a form to be administered into the oral cavity by means of a non-active device (one that operates on energy generated by the human body or by gravity) that delivers 4 mg or less of nicotine per dose for buccal absorption, or (e) in the form of a lozenge containing 4 mg or less of nicotine per dosage unit .
Documents
- The text in The British Columbia Gazette · January 22, 2019